Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Improving health outcomes through vaccines is a priority for the UK Health Security Agency (UKHSA). We aim to use UKHSA's capabilities across the full vaccine pathway to facilitate innovation and support the development and deployment of safe and effective vaccines, ensure the reliable and timely procurement, storage and distribution of vaccines, and drive increased uptake among the population to reduce the burden of infectious disease.
UKHSA published a Vaccine Prospectus in August 2026, which sets out the work that UKHSA and the wider health family do to sustain and grow the UK's world-leading role in immunisation. It details the scope of our programmes, our policy objectives, how we work with industry, and forthcoming opportunities to work with us.
The publication can be accessed here: https://www.gov.uk/government/publications/vaccine-prospectus-national-immunisation-programme-and-vaccine-products
Preliminary market engagement notice (UK2). The buyer wants to talk to suppliers before designing the procurement. Taking part is how to shape it.
Bids are submitted through the buyer’s own portal, not on this site. Read the full notice on Find a Tender before relying on any date here.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Jan 2030 – Jan 2030 | - | planning |